For oral cancer drugs with >1 formulation (tablet/capsule, higher strength/lower strength), is a product feature consistently associated with lower out-of-pocket costs for Medicare beneficiaries?
No, it's quite messy😕
Our work in @JGeriOnc
sciencedirect.com/science/articl…
No, it's quite messy😕
Our work in @JGeriOnc
sciencedirect.com/science/articl…